Persistent Nasal Symptoms and Loss of Smell post Covid

The Nasal Cavity in Long Covid: Neuroimmune Signalling, Smell Loss, and Persistent Symptoms

Introduction: Why the Nose Matters More Than We Think

The nasal cavity is often treated as a minor anatomical detail, relevant only during acute respiratory infection. In reality, it is one of the most biologically active interfaces between the external environment and the nervous and immune systems.

In Covid infection and Long Covid, nasal involvement extends far beyond congestion or loss of smell. It sits at the crossroads of immune activation, vascular regulation, and neural signalling. For some patients, persistent nasal and sensory symptoms may reflect ongoing neuroimmune disturbance rather than local disease alone.

Understanding the nasal cavity as a dynamic signalling hub helps clinicians make sense of symptoms that otherwise appear disconnected or unexplained.

---

ACE2 Expression and Early Viral Interaction

SARS CoV 2 binds efficiently to ACE2 receptors, which are highly expressed in nasal epithelial cells, particularly within the olfactory region. This receptor distribution explains why nasal symptoms and smell disturbance often appear early, sometimes before lower respiratory involvement.

Studies have demonstrated that viral RNA can persist in nasal tissues beyond the acute phase in some individuals. While this does not necessarily imply active infection, it supports the concept of prolonged local immune activation.

Importantly, olfactory dysfunction appears to result primarily from damage to sustentacular cells that support olfactory neurons, rather than widespread neuronal death. This distinction may help explain why recovery is possible yet unpredictable.

---

Persistent Smell Loss and Distortion After Covid

Anosmia, hyposmia, and parosmia remain among the most commonly reported Long Covid symptoms. Some individuals recover within weeks, while others experience distorted or absent smell for many months.

Parosmia, in particular, can be profoundly distressing. Patients often describe everyday smells as burnt, chemical, or nauseating. These symptoms are not merely sensory inconveniences. They affect appetite, mood, nutrition, and social functioning.

Clinicians should be aware that persistent smell disturbance may coexist with dizziness, cognitive complaints, and fatigue, suggesting broader nervous system involvement rather than isolated nasal pathology.

---

Neuroimmune Signalling and Central Sensitisation

The olfactory system has direct connections to limbic and autonomic brain regions. This makes it uniquely positioned to influence mood, arousal, and stress responses.

Persistent inflammation within the nasal mucosa may act as a chronic sensory input, amplifying neuroimmune signalling over time. In susceptible individuals, this may contribute to central sensitisation, where the nervous system becomes hyper responsive to otherwise mild stimuli.

This framework helps explain why some patients develop heightened sensitivity to smells, temperature changes, or environmental irritants long after viral clearance.

---

Mast Cell Activation and Nasal Hyperreactivity

The nasal mucosa contains a high density of mast cells. Post viral immune priming may lead to exaggerated mast cell responses, even in individuals without prior allergic disease.

Patients may report sneezing, burning, congestion, or facial pressure triggered by dust, fragrances, cold air, or changes in humidity. These reactions can fluctuate day to day, adding to patient confusion and distress.

While some individuals report partial symptom relief with antihistamines or mast cell stabilising strategies, evidence remains limited and largely observational. Clinicians should frame these options cautiously and avoid implying disease modification.

---

Vascular and Autonomic Contributions

Nasal tissues are richly vascularised and closely regulated by the autonomic nervous system. Altered autonomic tone or microvascular dysfunction may contribute to congestion, pressure, and temperature sensitivity without visible structural abnormalities.

This may be particularly relevant in patients with coexisting orthostatic intolerance, palpitations, or blood pressure variability. Nasal symptoms in these cases may reflect systemic autonomic imbalance rather than local inflammation alone.

---

Clinical Management Considerations

Management should remain proportionate and symptom focused.

Saline nasal irrigation is low risk and may provide symptomatic relief for dryness or congestion.

Intranasal corticosteroids or antihistamines may be appropriate in selected patients, with attention to mucosal tolerance and symptom response.

Clinicians should avoid over medicalising fluctuating symptoms or promising recovery timelines that cannot be supported by evidence.

Most importantly, acknowledging the biological plausibility of symptoms can reduce patient anxiety and improve therapeutic alliance.

---

Why This Matters in Long Covid Care

Persistent nasal and olfactory symptoms are often dismissed as minor or residual. For many patients, they are a daily reminder that recovery remains incomplete.

Viewing the nasal cavity as part of a wider neuroimmune network allows clinicians to integrate sensory symptoms into a coherent understanding of Long Covid, rather than treating them as isolated or psychosomatic complaints.

This perspective supports validation, careful monitoring, and realistic management rather than false reassurance or unnecessary escalation.

---

Disclaimer

This article is intended for educational purposes only. It does not replace individual clinical assessment, diagnostic evaluation, or specialist referral.

FAQs